Arlington Trust’s Doximity DOCS Stock Holding History

Arlington Trust’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-191	Closed	-$4.45K	–	864
2026 Q1	$4.45K	Buy	+191	New	+$5.95K	﹤0.01%	544

Other funds holding DOCS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Arlington Trust's DOCS Position: Q2 2026 in Review

Arlington Trust sold out of Doximity (DOCS) in Q2 2026, closing a stake of 191 shares — an estimated $4.45K sold.

Arlington Trust first reported a position in DOCS in Q1 2026 and held it in 1 quarter. The position peaked at $4.45K in Q1 2026. 358 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

Arlington Trust reported no remaining Doximity position as of Q2 2026 after selling out during the quarter.
Arlington Trust sold 191 Doximity shares in Q2 2026, an estimated $4.45K.
Arlington Trust first reported a position in Doximity in Q1 2026 and held it in 1 quarter.
Arlington Trust's Doximity position peaked at $4.45K in Q1 2026.
358 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.